Last updated: April 28, 2023
Sponsor: Karolinska Institutet
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sarcoma (Pediatric)
Uterine Fibroids
Uterina Myoma
Treatment
N/AClinical Study ID
NCT04240262
MYOMIC2
Ages > 25 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- premenopausal
- no future child wish
- acceptable risks for general anestesia or sedation
- willing to comply with protocol
Exclusion
Exclusion Criteria:
- current or future child wish
- bleeding disorder with increased risk of bleeding
Study Design
Total Participants: 200
Study Start date:
January 20, 2020
Estimated Completion Date:
July 31, 2024
Connect with a study center
Helena Kopp Kallner
Taby, 18352
SwedenActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.